您的购物车当前为空
别名 甲磺酸奈非那韦, Viracept, Nelfin, AG1343, AG 1343 Mesylate
Nelfinavir Mesylate (Viracept) 是一种口服活性的 HIV-1蛋白酶抑制剂,用于抑制 HIV 感染,是一种广谱抗癌剂。

Nelfinavir Mesylate (Viracept) 是一种口服活性的 HIV-1蛋白酶抑制剂,用于抑制 HIV 感染,是一种广谱抗癌剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 235 | In stock | |
| 5 mg | ¥ 599 | In stock | |
| 10 mg | ¥ 890 | In stock | |
| 25 mg | ¥ 1,880 | In stock | |
| 50 mg | ¥ 3,190 | In stock | |
| 100 mg | ¥ 5,600 | 5日内发货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,020 | In stock |
Nelfinavir Mesylate 相关产品
| 产品描述 | Nelfinavir Mesylate (Viracept) is an effective HIV protease inhibitor (Ki: 2 nM). |
| 靶点活性 | HIV protease:2 nM(Ki) |
| 激酶实验 | GTPγ[35S] binding assay: The cells are homogenized and centrifuged at 26900 × g for 30 min at 4°C. Membranes are re-suspended in 20 mM HEPES (pH 7.4), 100 mM NaCl, 10 mM MgCl2, 1 mM EDTA and 0.1% fat-free BSA at 2–3 mg protein/mL. GTPγ[35S] binding assay is performed with the membranes (75 mg protein /mL in 50 mM HEPES, 100 mM NaCl, 10 mM MgCl2, 20 μg/mL saponin and 0.1% fat-free BSA (pH 7.4), 5 mg/mL with wheat-germ agglutinin-coated scintillation proximity assay-bead, and 10 μM GDP for 10–15 min. The GTPγ[35S]-binding reaction is started by the addition of 200 pM GTPγ[35S]. After 120 min at room temperature, the plates are centrifuged for 10 min at 300 × g and counted. |
| 别名 | 甲磺酸奈非那韦, Viracept, Nelfin, AG1343, AG 1343 Mesylate |
| 分子量 | 663.89 |
| 分子式 | C33H49N3O7S2 |
| CAS No. | 159989-65-8 |
| Smiles | Cc1c(cccc1O)C(=O)N[C@@H](CSc1ccccc1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O.CS(=O)(=O)O |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | keep away from direct sunlight,store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 93 mg/mL (140.08 mM), Sonication is recommended. Ethanol: 93 mg/mL (140.08 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (7.53 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
| ||||||||||||||||||||||||||||||||||||
评论内容